Regencell Bioscience Holdings Stock Overlap Studies Hilbert Transform Instantaneous Trendline

RGC Stock  USD 5.52  0.34  5.80%   
Regencell Bioscience overlap studies tool provides the execution environment for running the Hilbert Transform Instantaneous Trendline study and other technical functions against Regencell Bioscience. Regencell Bioscience value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the Hilbert Transform Instantaneous Trendline study function is designed to identify and follow existing trends. Regencell Bioscience overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques.

Study
The minimum time period for execution of this function requires larger time horizon. Please increase the time horizon for this function. The output start index for this execution was zero with a total number of output elements of zero. The Instantaneous Trendline is a moving-average-like indicator which is formed by removing the Dominant Cycle from Regencell Bioscience price series.

Regencell Bioscience Technical Analysis Modules

Most technical analysis of Regencell Bioscience help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Regencell from various momentum indicators to cycle indicators. When you analyze Regencell charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Regencell Bioscience Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Regencell Bioscience Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Regencell Bioscience Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Regencell Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Regencell Bioscience's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Regencell Bioscience's intrinsic value. In addition to deriving basic predictive indicators for Regencell Bioscience, we also check how macroeconomic factors affect Regencell Bioscience price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2023 2024 (projected)
Interest Debt Per Share13.6214.3
Revenue Per Share23.2722.1
Hype
Prediction
LowEstimatedHigh
0.275.4514.66
Details
Intrinsic
Valuation
LowRealHigh
0.254.9214.13
Details
Naive
Forecast
LowNextHigh
0.126.2115.42
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
5.315.635.95
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Regencell Bioscience. Your research has to be compared to or analyzed against Regencell Bioscience's peers to derive any actionable benefits. When done correctly, Regencell Bioscience's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Regencell Bioscience.

Be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Generate Optimal Portfolios

Align your risk and return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Regencell Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Regencell Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Regencell Bioscience Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Regencell Bioscience Holdings Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regencell Bioscience Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regencell Bioscience. If investors know Regencell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regencell Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.33)
Return On Assets
(0.28)
Return On Equity
(0.43)
The market value of Regencell Bioscience is measured differently than its book value, which is the value of Regencell that is recorded on the company's balance sheet. Investors also form their own opinion of Regencell Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Regencell Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regencell Bioscience's market value can be influenced by many factors that don't directly affect Regencell Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regencell Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Regencell Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regencell Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.